In The News

From traditional to alternative health options, we provide the latest news links and resources…

Top 5 Myths About Women’s Heart Disease

To build awareness about heart disease in women, it is vitally important to know the myths and understand the facts. Myth #1 Heart disease is a man’s disease. The fact is that cardiovascular disease is the No 1 killer of women age 20 …

Have you heard of (MMS) Miracle Mineral Solution?

There is a new product sweeping the health and nutrition industry. It is called Miracle Mineral Solution (MMS).┬áThere are several books written on the subject, and Advanced Health Choices believes it deserves attention based not only on the products…

FDA Consumer Health Updates

Lilly Reports Second-Quarter 2012 Results, Raises 2012 EPS Guidance

http://photos.prnewswire.com/prnc/20031219/LLYLOGOINDIANAPOLIS, July 25, 2012 /PRNewswire/ –

Worldwide revenue declined 10 percent to $5.6 billion, driven by Zyprexa patent expirations, partially offset by significant growth in other products.
Cymbalta revenue increased 22 percent due to continued strong growth in both the U.S. and…


Regeneron Reports Second Quarter 2012 Financial and Operating Results

TARRYTOWN, N.Y., July 25, 2012 /PRNewswire/ – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial and operating results for the second quarter of 2012 and provided an update on development programs. 

The Company reported total revenues of $304 million in…

Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.

NEWARK, N.J., July 25, 2012 /PRNewswire/ – Actinium Pharmaceuticals Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that the Company made a regulatory milestone payment to Abbott Biotherapeutics Corp. following the…